Symmetric Dimethylarginine
Also known as: SDMA
What Does Symmetric Dimethylarginine Measure?
Symmetric Dimethylarginine (SDMA) is a naturally occurring amino acid byproduct that is released into the bloodstream when proteins containing methylated arginine residues are broken down. It is produced inside the nucleus of cells throughout the body as a result of normal protein metabolism and is freely filtered by the kidneys. Blood levels of SDMA reflect how efficiently the kidneys are filtering waste products from the blood, making it a highly sensitive marker of glomerular filtration rate (GFR) — the primary measure of kidney function.
Why Does Symmetric Dimethylarginine Matter?
SDMA is clinically significant because it rises earlier than many traditional kidney markers, such as creatinine, when kidney function begins to decline. Studies suggest SDMA can detect reduced kidney filtration capacity when as little as 25-40% of kidney function is lost, whereas creatinine may not elevate noticeably until 50-75% of function is lost. Unlike creatinine, SDMA levels are not significantly affected by muscle mass, diet, or physical activity, making it a more reliable and unbiased indicator of kidney health across diverse patient populations, including the elderly, malnourished individuals, and those with low muscle mass. Beyond kidney function, SDMA also inhibits the enzyme nitric oxide synthase, which can contribute to reduced nitric oxide production, endothelial dysfunction, and increased cardiovascular risk when chronically elevated.
Normal Ranges
Males
< 0.50 µmol/L (or approximately 0.00–96 ng/mL depending on laboratory method)
Females
< 0.50 µmol/L (or approximately 0.00–96 ng/mL depending on laboratory method)
Children
Varies by age; generally slightly lower than adult values, typically < 0.45 µmol/L
Causes of High Levels
- Chronic kidney disease (CKD) — the most common cause, as declining glomerular filtration reduces SDMA clearance
- Acute kidney injury — sudden loss of kidney function causes rapid SDMA accumulation
- Cardiovascular disease — reduced renal perfusion and endothelial dysfunction can elevate SDMA
- Hypertension — chronic high blood pressure damages kidney filtration units over time
- Diabetes mellitus — diabetic nephropathy progressively impairs kidney filtration capacity
- Protein hypercatabolism — excessive protein breakdown (e.g., in severe illness, sepsis, or trauma) increases SDMA production
Causes of Low Levels
- Overhydration or fluid overload — dilution of blood plasma can lower measured SDMA concentration
- Reduced protein turnover — low protein intake or malnutrition can decrease SDMA production
How to Improve Your Symmetric Dimethylarginine
Diet
- Reduce sodium intake to less than 2,300 mg per day to lower blood pressure and protect kidney function
- Limit dietary protein to 0.6–0.8 g/kg body weight per day if advised by a nephrologist to reduce kidney workload in CKD
- Increase intake of anti-inflammatory foods such as berries, leafy greens, and omega-3 rich fish to support vascular and kidney health
- Avoid processed foods and high-phosphorus additives that accelerate kidney disease progression
- Stay well hydrated with 6–8 glasses of water daily to support optimal glomerular filtration
Supplements
- Omega-3 fatty acids (2–4 g/day of EPA+DHA) — shown to reduce inflammation and support kidney blood flow
- Coenzyme Q10 (100–300 mg/day) — may improve mitochondrial function in kidney cells and reduce oxidative stress
- L-arginine (3–6 g/day with physician guidance) — may help restore nitric oxide balance inhibited by elevated SDMA, but use cautiously in kidney disease
- Vitamin D3 (1,000–2,000 IU/day) — deficiency is common in CKD and supplementation may slow disease progression
- Alpha-lipoic acid (300–600 mg/day) — antioxidant that may reduce oxidative kidney damage
Related Biomarkers
Frequently Asked Questions
What is the difference between SDMA and creatinine for measuring kidney function?
Both SDMA and creatinine are used to assess kidney function, but SDMA has a key advantage: it is not influenced by muscle mass, diet, or hydration status to the same degree as creatinine. Creatinine is produced by muscle metabolism, so muscular individuals may have higher creatinine levels even with normal kidneys, while frail or elderly patients may have falsely low creatinine despite impaired kidney function. SDMA is produced uniformly by all nucleated cells in the body through protein methylation, making it a more consistent and earlier indicator of kidney decline across all body types.
Can elevated SDMA cause heart problems?
Yes, chronically elevated SDMA is associated with cardiovascular risk. SDMA competes with L-arginine for cellular uptake, which reduces the availability of arginine for nitric oxide (NO) production. Nitric oxide is essential for keeping blood vessels relaxed and preventing endothelial dysfunction — a key step in the development of atherosclerosis, hypertension, and heart disease. This means elevated SDMA not only signals kidney trouble but may independently contribute to vascular damage and increased risk of heart attack and stroke.
Is SDMA tested routinely in standard blood panels?
SDMA is not yet included in most standard basic or comprehensive metabolic panels in human medicine. It is more commonly used in veterinary medicine, particularly for early detection of feline kidney disease. In human medicine, SDMA testing is available as a specialized biomarker through certain clinical laboratories, particularly in the context of nephrology workups or cardiovascular risk assessment. Researchers and clinicians are increasingly recognizing its value, and it may become more routine as testing costs decrease and clinical guidelines evolve.